Bigbear Pharmaceutical·Medication Guide

• Side effects and adverse reactions of Anagrelide

  Anagrelide is primarily used to treat thrombocytosis, especially essential thrombocytosis, reducing the risk of thrombosis and improving patients'···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 116

• Detailed information on the targeted drug Braftovi (Entofen)

  Braftovi is a targeted therapy specifically for BRAF V600E gene mutations. It is often used in combination with other drugs (such as cetuximab and bim···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 119

• instruction manual for the targeted drug Encorafenib

  Encorafenib is an oral small-molecule BRAF kinase inhibitor developed and manufactured by Pierre Fabre in France. It received marketing approval from ···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 114

• Encorafenib side effects: serious adverse reactions, common side effects, side effect management

  Encorafenib is an oral small-molecule BRAF kinase inhibitor developed and manufactured by Pierre Fabre in France. In 2018, encorafenib received market···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 136

• Encorafenib (Braftovi) Patient Guide: Uses, Side Effects, and What to Expect

  Encorafenib exerts its anti-tumor effect by specifically inhibiting the activity of BRAF mutant protein, thereby blocking tumor cell proliferation and···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 125

• FDA-approved indications and approval history for each indication of Encorafenib

  Since its initial FDA approval in 2018 for the treatment of melanoma, encorafenib has continued to expand its indications, bringing new treatment opti···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 118

• The FDA has approved sotorarazib (Lumakras) in combination with panitumumab

  Here is the professional, accurate English translation of the full text, formatted for medical/pharmaceutical documentation:On May 28, 2021, Amgen ann···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 119

• The FDA has approved sotorarazib (Lumakras) in combination with panitumumab

  On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the combination of sottorazib (Lumakras) and panitu···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 114

• Important Precautions During Ponatinib Administration

  Ponatinib is an oral medication mainly used for the treatment of specific types of chronic myeloid leukemia and acute lymphoblastic leukemia. It inhib···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 115

• What Is Ponatinib Used For

  Ponatinib is a third‑generation tyrosine kinase inhibitor (TKI) indicated for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromos···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 110

• How should I take alectinib

  Take alectinib exactly as your healthcare provider tells you to take it. Do not change your dose or stop taking alectinib unless your healthcare provi···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 115

• What should I tell my doctor before taking alectinib

  Before you take alectinib, tell your healthcare provider about all of your medical conditions, including if you:have liver problemshave lung or breath···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 122

• What should I avoid while taking alectinib

  Avoid spending time in the sunlight during treatment with alectinib and for 7 days after the final dose of alectinib. You may burn more easily and get···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 112

• What is alectinib used for

  Alectinib is a prescription medicine used to treat people with NSCLC:1.that is caused by an abnormal ALK gene, and2.that has spread to other parts of ···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 110

• Price and Purchase Channels of Alectinib

  Price of Alectinib per BoxAlectinib is a targeted drug for ALK-positive metastatic non-small cell lung cancer, developed by Roche (Switzerland) and ap···【Read More】

  Update: 2026-03-04Source: Haiou HealthViews: 105